99 related articles for article (PubMed ID: 15052637)
21. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
22. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
[TBL] [Abstract][Full Text] [Related]
23. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
[TBL] [Abstract][Full Text] [Related]
24. High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch.
Gaillet B; Gilbert R; Broussau S; Pilotte A; Malenfant F; Mullick A; Garnier A; Massie B
Biotechnol Bioeng; 2010 Jun; 106(2):203-15. PubMed ID: 20178120
[TBL] [Abstract][Full Text] [Related]
25. pTRIDENT, a novel vector family for tricistronic gene expression in mammalian cells.
Fussenegger M; Mazur X; Bailey JE
Biotechnol Bioeng; 1998 Jan; 57(1):1-10. PubMed ID: 10099172
[TBL] [Abstract][Full Text] [Related]
26. pLR: a lentiviral backbone series to stable transduction of bicistronic genes and exchange of promoters.
Vargas JE; Salton G; Sodré de Castro Laino A; Pires TD; Bonamino M; Lenz G; Delgado-Cañedo A
Plasmid; 2012 Nov; 68(3):179-85. PubMed ID: 22728068
[TBL] [Abstract][Full Text] [Related]
27. Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
Greenberg KP; Geller SF; Schaffer DV; Flannery JG
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1844-52. PubMed ID: 17389520
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells.
Ben-Dor I; Itsykson P; Goldenberg D; Galun E; Reubinoff BE
Mol Ther; 2006 Aug; 14(2):255-67. PubMed ID: 16632408
[TBL] [Abstract][Full Text] [Related]
29. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
30. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
31. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch.
Gaillet B; Gilbert R; Amziani R; Guilbault C; Gadoury C; Caron AW; Mullick A; Garnier A; Massie B
Biotechnol Prog; 2007; 23(1):200-9. PubMed ID: 17269689
[TBL] [Abstract][Full Text] [Related]
32. Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases.
Mock U; Riecken K; Berdien B; Qasim W; Chan E; Cathomen T; Fehse B
Sci Rep; 2014 Sep; 4():6409. PubMed ID: 25230987
[TBL] [Abstract][Full Text] [Related]
33. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
34. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
Mitta B; Rimann M; Fussenegger M
Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
[TBL] [Abstract][Full Text] [Related]
35. 6-hydroxy-nicotine-inducible multilevel transgene control in mammalian cells.
Malphettes L; Schoenmakers RG; Fussenegger M
Metab Eng; 2006 Nov; 8(6):543-53. PubMed ID: 16962351
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
37. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences.
Ibrahimi A; Vande Velde G; Reumers V; Toelen J; Thiry I; Vandeputte C; Vets S; Deroose C; Bormans G; Baekelandt V; Debyser Z; Gijsbers R
Hum Gene Ther; 2009 Aug; 20(8):845-60. PubMed ID: 19419274
[TBL] [Abstract][Full Text] [Related]
38. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
39. In vivo transduction of HIV-1-derived lentiviral particles engineered for macrolide-adjustable transgene expression.
Mitta B; Weber CC; Fussenegger M
J Gene Med; 2005 Nov; 7(11):1400-8. PubMed ID: 15999397
[TBL] [Abstract][Full Text] [Related]
40. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]